GSK announced a $30 billion investment plan across the United States over the next five years, expanding its research, development, and supply ch ...

LatticeFlow AI sets a new standard in AI governance with deep technical assessments that enable evidence-based decisions and empower enterprises to accelerate their AI advantage.

We spoke with Castle Bioscience's Dr. Rebecca Critchley-Thorne about AI-enabled spatial proteomics, TissueCypher’s impact on ...